Pharmaceutical Company Charged With Deceptive Practices in Opioid Scandal – News

Arizona Attorney General Mark Brnovich is charging a local pharmaceutical company of using deceptive marketing practices to boost their profits at the cost of public health. Brnovich filed a lawsuit in Maricopa County Superior Court, which accuses Insys Therapeutics of deceiving patients, doctors, and insurers in regards to the safety of their product Subsys, a spray-on version of the dangerous opioid fentanyl.

“Insys lied to insurers, concealed key facts from doctors and patients, and paid doctors sham ‘speaker fees’ in exchange for writing prescriptions, all in order to increase the sales of Subsys, without regard for the health and safety of patients,” the suit alleges. “Insys made hundreds of millions of dollars from its deceptive scheme, but also put countless patients in harm’s way, exposing them to unacceptable and unnecessary risks of addiction and death.”

According to Brnovich, the FDA only approved Subsys to manage “breakthrough pain in cancer patients 18 years of age and older who are receiving and tolerant to around-the-block opioid therapy for their underlying persistent cancer pain.” The drug is not authorized for use for other ailments…

Continue reading at

About Merry Jane

is the definitive cannabis resource on culture, news, video, food and style dedicated to expressing a new cannabis mentality. Through exclusive content and relatable perspectives, MERRY JANE highlights the best of cannabis lifestyle while also offering vital, interactive tools to explore the new frontier of products, dispensaries and community.

Leave a Reply

Your email address will not be published. Required fields are marked *